• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 11-K filed by Envista Holdings Corporation

    6/11/25 4:13:17 PM ET
    $NVST
    Medical/Dental Instruments
    Health Care
    Get the next $NVST alert in real time by email
    11-K 1 nvst12312411ksavingsplan.htm 11-K Document


    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549
     
    FORM 11-K

    FOR ANNUAL REPORTS OF EMPLOYEE STOCK PURCHASE, SAVINGS AND SIMILAR
    PLANS PURSUANT TO SECTION 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

     (Mark One)
    ýANNUAL REPORT PURSUANT TO SECTION 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

    For the fiscal year ended December 31, 2024

    OR
     
    ¨TRANSITION REPORT PURSUANT TO SECTION 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
    For the transition period from         to    

    Commission file number: 001-39054

    A.Full title of the plan and the address of the plan, if different from that of the issuer named below:

    Envista Holdings Corporation Savings Plan
     
    B.Name of issuer of the securities held pursuant to the plan and the address of its principal executive office:

    Envista Holdings Corporation
    200 S. Kraemer Blvd., Building E
    Brea, CA 92821-6208
    714-817-7000





    ENVISTA HOLDINGS CORPORATION SAVINGS PLAN
    TABLE OF CONTENTS
    FORM 11-K
     
     Page
      
    Report of Independent Registered Public Accounting Firm
    1
    Statements of Net Assets Available for Benefits as of December 31, 2024 and 2023
    2
    Statement of Changes in Net Assets Available for Benefits for the year ended December 31, 2024
    3
    Notes to Financial Statements
    4
    Supplemental Information
    10
    Signature
    12
    Exhibit Index
    13




    Report of Independent Registered Public Accounting Firm

    To the 401(k) Committee
    Envista Holdings Corporation Savings Plan
    200 S. Kraemer Blvd., Building E
    Brea, CA 92821

    Opinion on the Financial Statements

    We have audited the accompanying statements of net assets available for benefits of the Envista Holdings Corporation Savings Plan (the “Plan”) as of December 31, 2024 and 2023, the related statement of changes in net assets available for benefits for the year ended December 31, 2024, and the related notes (collectively, the “financial statements”). In our opinion, the financial statements present fairly, in all material respects, the net assets available for benefits of the Plan as of December 31, 2024 and 2023, and the changes in net assets available for benefits for the year ended December 31, 2024, in conformity with accounting principles generally accepted in the United States of America.

    Basis for Opinion

    These financial statements are the responsibility of the Plan’s management. Our responsibility is to express an opinion on the Plan’s financial statements based on our audit. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (“PCAOB”) and are required to be independent with respect to the Plan in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

    We conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. The Plan is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audit we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the Plan’s internal control over financial reporting. Accordingly, we express no such opinion.

    Our audit included performing procedures to assess the risk of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audit also included evaluating the accounting principles used and significant estimates made by the Plan’s management, as well as evaluating the overall presentation of the financial statements. We believe that our audit provide a reasonable basis for our opinion.

    Supplemental Information

    The supplemental information in the accompanying schedules of Schedule H, line 4i, - Schedule of Assets (Held At End of Year) as of December 31, 2024 and of Schedule H, line 4a, - Schedule of Delinquent Participant Contributions for the year ended December 31, 2024 has been subjected to audit procedures performed in conjunction with the audit of the Plan’s financial statements. The supplemental information is presented for the purpose of additional analysis and is not a required part of the financial statements but included supplemental information required by the Department of Labor’s Rules and Regulations for Reporting and Disclosure under the Employee Retirement Income Security Act of 1974. The supplemental information is the responsibility of the Plan’s management. Our audit procedures included determining whether the supplemental information reconciles to the financial statements or the underlying accounting and other records, as applicable, and performing procedures to test the completeness and accuracy of the information presented in the supplemental information. In forming our opinion on the supplemental information, we evaluated whether the supplemental information, including its form and content, is presented in conformity with the Department of Labor’s Rules and Regulations for Reporting and Disclosure under the Employee Retirement Income Security Act of 1974. In our opinion, the supplemental information is fairly stated, in all material respects, in relation to the financial statements as a whole.

    /s/ BDO USA, P.C.

    We have served as the Plan’s auditor since 2024.

    Costa Mesa, CA
    June 11, 2025


    1


    ENVISTA HOLDINGS CORPORATION SAVINGS PLAN
    STATEMENTS OF NET ASSETS AVAILABLE FOR BENEFITS
    AS OF DECEMBER 31, 2024 AND 2023
    ($ in thousands)
     
    ASSETS20242023
    Investments
      Money market funds$2,635.8 $476.1 
      Envista stock fund3,491.5 4,109.0 
      Mutual funds20,157.7 18,116.6 
      Common/collective trusts495,313.2 449,053.9 
      Self-directed brokerage account55,948.3 44,078.6 
    Total Investments577,546.5 515,834.2 
    Receivables: 
    Participant contributions— 291.2 
    Employer contributions7,081.1 150.4 
    Notes receivable from participants7,020.1 6,694.1 
    Total receivables14,101.2 7,135.7 
    NET ASSETS AVAILABLE FOR BENEFITS$591,647.7 $522,969.9 

    See the accompanying notes to the financial statements.

    2


    ENVISTA HOLDINGS CORPORATION SAVINGS PLAN
    STATEMENT OF CHANGES IN NET ASSETS AVAILABLE FOR BENEFITS
    FOR THE YEAR ENDED DECEMBER 31, 2024
    ($ in thousands)

    ADDITIONS 
    Contributions: 
    Participants$28,233.4 
    Rollovers3,723.2 
    Employer19,419.6 
    Total contributions51,376.2 
    Interest income on notes receivable from participants537.9 
    Interest and dividend income2,393.6 
    Net appreciation of the fair value of investments78,856.7 
    Total additions133,164.4 
    DEDUCTIONS
    Benefit payments(64,145.0)
    Administrative expenses(341.6)
    Total deductions(64,486.6)
    NET INCREASE IN ASSETS AVAILABLE FOR BENEFITS68,677.8 
    NET ASSETS AVAILABLE FOR BENEFITS: 
    Beginning of period522,969.9 
    End of year$591,647.7 

    See the accompanying notes to the financial statements.

    3


    ENVISTA HOLDINGS CORPORATION SAVINGS PLAN
    NOTES TO FINANCIAL STATEMENTS
     
    NOTE 1. DESCRIPTION OF THE PLAN

    The following description of the Envista Holdings Corporation Savings Plan (the “Plan”) provides only general information. Participants should refer to the plan document and summary plan description for a more complete description of the Plan’s provisions.

    General

    The Plan is a defined contribution plan established on December 18, 2019, for eligible full-time and part-time non-union employees of Envista Holdings Corporation (“Envista,” the “Company” or the “Plan Sponsor”) and its subsidiaries. The Plan is subject to the provisions of the Employee Retirement Income Security Act of 1974, as amended (“ERISA”) and the U.S. Internal Revenue Code of 1986, as amended (the “Code”). On September 28, 2020, the Envista Holdings Corporation Union Savings Plan merged into the Plan (the “Plan Merger”). After the Plan Merger, eligible union and non-union employees can participate in the Plan.

    The Plan is administered by the 401(k) Committee of Envista (the “Committee”) which has overall responsibility for the operation and administration of the Plan. The Committee determines the appropriateness of the Plan’s investment offerings and monitors investment performance. Fidelity Workplace Services LLC provides recordkeeping and related services to the Plan and Fidelity Management Trust Company is the trustee to the Plan (together, “Fidelity”).

    Contributions

    Employee Contributions – Eligible participants may contribute up to 75% of their eligible compensation (subject to annual maximums). Employee contributions and the earnings or losses thereon are fully vested at all times. For the non-union employees, the Plan has an auto-enrollment feature whereby, unless a newly-hired employee affirmatively elects otherwise, contributions equal to 5% of eligible compensation are made into the Plan beginning with the payroll period beginning on the 45th day following the date that they are notified of this feature, or as soon as administratively practicable thereafter. Union employees are not auto-enrolled in the Plan. Furthermore, eligible participants who are age fifty or older, or who are projected to attain age fifty by the end of the plan year can make catch up contributions as a separate dollar amount election (subject to annual maximum). Eligible participants can also rollover their eligible contributions from their former employer’s retirement plan to the Plan.

    Employer Contributions – Non-Union Participants
    Non-union participants are immediately eligible to receive Company safe harbor matching contributions each payroll period of 100% of the first 3% of eligible compensation contributed by the participant plus 50% of the next 2% of eligible compensation contributed. Employees are immediately 100% vested in all safe harbor contributions. Company safe harbor matching contributions made during the 2024 plan year were $12.7 million.

    For non-union employees, in addition to the Company’s safe harbor contributions, after participants complete one year of service, the Company may make additional retirement contributions on behalf of the participants. This discretionary contribution may equal up to 2% of eligible participants’ eligible pay. The Company made discretionary contributions in the amount of $6.3 million for the 2024 plan year in March 2025. In addition, retirement contributions of up to 2% of annual eligible earnings above the Social Security wage base and below the maximum eligible wages as determined by the Internal Revenue Service (“IRS”) may be contributed by the Company to participants’ accounts subsequent to the Plan year end. In March 2025, the Company made a discretionary retirement contribution amount of $0.7 million for eligible earnings above the Social Security wage base and below the maximum eligible wage into the Plan for the 2024 plan year. The Company’s discretionary retirement contributions are determined at the discretion of the Plan Sponsor. With respect to all discretionary retirement contributions, participants generally become fully vested on the earlier of completing three years of service, retirement at or after age 65, complete disability or death.

    4


    Employer Contribution – Union Participants

    Per the terms of the applicable collective bargaining agreement, union participants are eligible for Company matching contributions and additional non-elective employer contributions upon completion of one year of service. Company matching contributions and non-elective employer contributions made during the 2024 plan year were $61,736 and $125,775, respectively. Generally, participants become fully vested with respect to the employer contributions upon completion of three years of service, attainment of age 65, death, complete disability, or as required pursuant to the terms of the applicable collective bargaining agreement.

    Forfeitures

    A participant’s non-vested balance is forfeited at the time of termination of employment. Forfeitures may be used to pay Plan expenses or to offset future Company contributions.  If a participant is rehired within five years after termination, their forfeited amount is reinstated. During 2024, $524,916 of the forfeiture fund was used to pay for Company safe harbor matching contributions. As of December 31, 2024 and 2023 forfeiture balances were $16,607 and $323,738, respectively.

    Benefit Payments

    A participant who attains normal retirement age (age 65) shall be entitled to payment of the balance in their account. A participant who remains employed after attainment of normal retirement age shall continue to participate under the same terms and conditions as applied prior to reaching normal retirement age. A participant must begin receiving distributions no later than April 1, following the later of the year in which they retire from the Company or the calendar year in which they reach the age of 72 (for participants who attained age 70 ½ before January 1, 2020).

    The beneficiary or beneficiaries of a deceased participant shall be entitled to payment of the participant’s account balance within a reasonable period of time after the participant’s death.

    Upon total and permanent disability, a participant shall be entitled to payment of the balance in their account within a reasonable period of time after termination of employment.

    Upon a participant’s termination of employment for reasons other than as specified above, a participant is entitled to payment of their vested account balance. If the vested value of the participant’s account is $1,000 (applied separately to Roth and non-Roth balances) or less, payment will automatically be made in a single lump sum. If the vested value of the participant’s Roth or non-Roth balances is greater than $1,000 and does not exceed $7,000, Fidelity will automatically rollover the Roth or non-Roth balances to a separate Fidelity Individual Retirement Account, unless the participant elects a direct rollover or payment before that time. If the vested value of the participant’s account is more than $7,000, the participant must contact Fidelity to request a distribution.

    Eligible participants may request a withdrawal of all or a portion of their vested account while still working for the Company, subject to certain limitations and tax penalties.

    Notes Receivable from Participants

    A participant may receive a loan from the Plan in accordance with the policy established by the Plan Sponsor. Any such loan or loans must be for at least $1,000 and shall not exceed the lesser of 50% of the participant’s vested account balance or $50,000 reduced by the participant’s highest outstanding loan balance in the Plan during the one-year period ending on the day before the loan is made. The Committee establishes the maximum maturity period that is permitted to prevent the loan from being treated as a distribution.

    The interest rate for any loan is a minimum of 1% over the Federal prime rate as published on the last business day of the month by the Federal Reserve and is fixed for the term of each loan. Repayment terms are generally one to five years. Interest and principal payments are deducted from participants’ paychecks each pay period and are credited to participants’ Plan accounts according to their investment election for new contributions in effect at the time repayments are made. The entire loan balance may be paid in full without penalty at any time, by certified check, cashier’s check, or money order.

    5


    Participant Accounts

    Each participant account is credited with the participant’s contributions, employer contributions, and an allocation of Plan earnings or losses, and is charged quarterly with administrative expenses and recordkeeping fees. The benefit to which a participant is entitled is the participant’s vested account.

    Administrative Expenses

    The Plan’s administrative expenses are paid by the Plan, as provided by the Plan’s provisions. Expenses relating to purchases, sales or transfers of the Plan’s investments are charged to the particular investment fund to which the expenses relate.

    Termination of the Plan

    Although the Company, as the Plan Sponsor, has not expressed an intention to do so, the Plan may be terminated at any time. In the event of termination of the Plan, the account balances of participants as of the date of termination shall immediately become vested.

    6


    NOTE 2. SIGNIFICANT ACCOUNTING POLICIES

    Basis of Accounting

    The accompanying financial statements have been prepared in accordance with accounting principles generally accepted in the United States (“GAAP”).

    Use of Estimates

    The preparation of financial statements in conformity with GAAP requires management to make estimates and judgments that affect the reported amounts of assets, liabilities and changes therein, and the related disclosure of contingent assets and liabilities. Actual results could differ from those estimates.

    Risks and Uncertainties

    Investment securities are exposed to various risks such as interest rates, credit risk and overall market volatility risk. Due to the level of risk associated with certain investment securities, it is at least reasonably possible that changes in the values of investment securities will occur in the near term and that such changes could materially affect participants’ account balances and the amounts reported in the Statements of Net Assets Available for Benefits. Given all these factors and the dynamic nature of and volatility in the U.S. financial markets, it is difficult to predict the future impact to the values of the Plan’s investments.

    Notes Receivable from Participants

    Notes receivable from participants represent participant loans and are recorded at their unpaid principal balance plus any accrued but unpaid interest. Interest income on notes receivable from participants is recorded when it is earned. Related fees are recorded as administrative expenses and are expensed when they are incurred. If a participant ceases to make loan repayments and has reached a distributable event, the loan balance is reduced and a benefit payment is recorded.

    Investment Valuation and Income Recognition

    Investments are reported at fair value. Fair value is the price that would be received upon the sale of an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. Refer to Note 3 for discussion of fair value measurements.

    Purchases and sales of securities are recorded on a trade date basis. Interest income is recorded on an accrual basis, while dividends are recorded on the ex-dividend date. Net appreciation includes the Plan’s gains and losses on investments bought and sold as well as held during the year.

    Payment of Benefits

    Benefits are recorded when paid.

    Subsequent Events

    Management has evaluated subsequent events through the date these financial statements were issued, and determined that there were no events or transactions, except as described below, which require recognition or disclosure in these financial statements.

    Effective January 1, 2025, the Plan Sponsor restated the Envista Holdings Corporation Savings Plan, which eliminated service and vesting requirements for the employer discretionary retirement contributions. The restatement also updated such items as: the IRS limits for 2025, removed the provisions related to the spin-off of the Plan from the Danaher Savings Plan that no longer apply, and added plan language to clarify temporary employee administration.

    7


    NOTE 3. FAIR VALUE MEASUREMENTS

    Accounting standards define fair value based on an exit price model, establish a framework for measuring fair value where the Plan’s assets and liabilities are required to be carried at fair value and provide for certain disclosures related to the valuation methods used within a valuation hierarchy. This hierarchy prioritizes the inputs into three broad levels. Level 1 inputs are quoted prices (unadjusted) in active markets for identical assets or liabilities. Level 2 inputs are quoted prices for similar assets and liabilities in active markets, quoted prices for identical or similar assets in markets that are not active, or other observable characteristics for the asset or liability, including interest rates, yield curves and credit risks, or inputs that are derived principally from, or corroborated by, observable market data through correlation. Level 3 inputs are unobservable inputs based on our assumptions. A financial asset or liability’s classification within the hierarchy is determined based on the lowest level input that is significant to the fair value measurement in its entirety.

    The Plan provides for some investments that are valued using Net Asset Value (“NAV”) as a practical expedient. However, none of these investments have limits on their redemption or have commitments. Investments valued using NAV as a practical expedient consist primarily of common collective trusts which allow the Plan to allocate investments across a broad array of types of funds and diversify the portfolio.

    The fair values of the Plan’s investments as of December 31, 2024, by asset category, were as follows ($ in thousands):

    Quoted Prices in Active Market
    (Level 1)
    Significant Other Observable Inputs
    (Level 2)
    Significant Unobservable Inputs
    (Level 3)
    Total
    Money market funds$2,635.8 $— $— $2,635.8 
    Envista Stock Fund3,491.5 — — 3,491.5 
    Mutual funds20,157.7 — — 20,157.7 
    Self-directed brokerage account55,948.3 — — 55,948.3 
     $82,233.3 $— $— $82,233.3 
    Investments measured at NAV as a practical expedient (a)
        
    Common/collective trusts   495,313.2 
    Total investments in the Plan, at fair value   $577,546.5 
    (a) The fair value amounts presented in the table above are intended to permit reconciliation of the fair value hierarchy to the total of plan assets.

    The fair values of the Plan’s investments as of December 31, 2023, by asset category, were as follows ($ in thousands):
    Quoted Prices in Active Market
    (Level 1)
    Significant Other Observable Inputs
    (Level 2)
    Significant Unobservable Inputs
    (Level 3)
    Total
    Money market funds$476.1 $— $— $476.1 
    Envista Stock Fund4,109.0 — — 4,109.0 
    Mutual funds18,116.6 — — 18,116.6 
    Self-directed brokerage account44,078.6 — — 44,078.6 
     $66,780.3 $— $— $66,780.3 
    Investments measured at NAV as a practical expedient (a)
        
    Common/collective trusts   449,053.9 
    Total investments in the Plan, at fair value   $515,834.2 
    (a) The fair value amounts presented in the table above are intended to permit reconciliation of the fair value hierarchy to the total of plan assets.

    8


    Following is a description of the valuation techniques and inputs used for each major class of assets measured at fair value.

    •Money market funds and mutual funds are valued at the quoted closing price reported on the active market on which the individual securities are traded.

    •The Envista Stock Fund consists of shares of the Company’s stock and short-term money market investments and is valued based on the quoted market price of the investments. The Plan restricts each participant’s holdings in the Envista Stock Fund to no more than 25% of their account balance.

    •The self-directed brokerage accounts consist of common stock, mutual funds and other investments, which are valued at the last reported sales price on the last business day of the year, and uninvested cash, which is recorded at carrying value as maturities are less than three months.

    •The common/collective trusts are valued at NAV as a practical expedient based on the Plan’s interest, represented by investment units, in the underlying investments held within the trust that are traded in an active market by the trustee.

    The methods described above may produce a fair value estimate that may not be indicative of net realizable value or reflective of future fair values. Furthermore, while the Plan believes the valuation methods are appropriate and consistent with the methods used by other market participants, the use of different methodologies or assumptions to determine the fair value of certain financial instruments could result in a different fair value measurement at the reporting date.

    NOTE 4. TAX STATUS OF THE PLAN

    The Plan received a favorable determination letter from the IRS on February 28, 2023. Plan management believes that the Plan is designed and being operated in compliance with the applicable requirements of the Code and, therefore is qualified and tax-exempt.

    Accounting standards require Plan management to evaluate uncertain tax positions taken by the Plan. The financial statement effects of a tax position are recognized when the position is more likely than not, based on the technical merits, to be sustained upon examination by the IRS. The Plan Sponsor has analyzed the tax positions taken by the Plan and has concluded that there are no uncertain positions taken or expected to be taken that would require recognition of a liability or disclosure in the financial statements as of December 31, 2024 and 2023. The Plan has recognized no interest or penalties related to uncertain tax positions. The Plan is subject to routine audits by taxing jurisdictions; however, there are currently no audits of the Plan for any tax periods in progress.

    NOTE 5. RELATED PARTY TRANSACTIONS AND PARTIES IN INTEREST TRANSACTIONS

    Certain investments are held in shares of mutual funds issued by affiliates of Fidelity. In addition, the Plan paid Fidelity administrative expenses in the amount of $341,635 during the year ended December 31, 2024. Fidelity is the trustee as defined by the Plan; therefore, these are party in interest transactions. Additionally, as of December 31, 2024 and 2023, the Plan held 180,812 and 170,695 shares of Envista common stock within the Envista Stock Fund, respectively.

    The Company failed to timely remit participant contributions to the Plan for plan year 2023 and 2024 as noted in supplemental table Form 5500, Schedule H, Line 4A. These transactions constitute prohibited transactions as defined by ERISA. The contributions were remitted to the Plan in the respective years, and the 2024 lost earnings are in the process of being funded to the Plan.
    9



    SUPPLEMENTAL INFORMATION

    ENVISTA HOLDINGS CORPORATION SAVINGS PLAN
    EIN: 83-2206728, PLAN NO. 001
    FORM 5500, SCHEDULE H, LINE 4A -
    SCHEDULE OF DELINQUENT PARTICIPANT CONTRIBUTIONS
    AS OF DECEMBER 31, 2024
    *Participant Contributions Transferred Late to PlanTotal that Constitutes Nonexempt Prohibited Transactions
    Check here if Late Participant Loan Repayments are included:
    a2024-06x12_23x30x23a.jpg
    Contributions Not CorrectedContributions Corrected Outside VFCP**Contributions Pending Correction in VFCP**Total Fully Corrected Under VFCP and PTE 2002-51
    Year
    2023$82,990 $— $82,990 $— $— 
    2024$196,087 $— $196,087 $— $— 
    *Parties-in-interest.
    **Voluntary Fiduciary Correction Program
    10



    ENVISTA HOLDINGS CORPORATION SAVINGS PLAN
    EIN: 83-2206728, PLAN NO. 001
    FORM 5500, SCHEDULE H, LINE 4i -
    SCHEDULE OF ASSETS (HELD AT END OF YEAR)
    AS OF DECEMBER 31, 2024
    (a)(b) Identity of issue, borrower, lessor or similar party(c) Description of investment including maturity date, rate of interest, collateral, par, or maturity value(d) Cost** (e) Current value
    Vanguard Federal Money Market Fund Investor SharesMoney Market$33,962 
    Allspring 100% Treasury Money Market Fund - Class InstMoney Market2,601,872 
    Total$2,635,834 
    *Envista StockEnvista Stock Fund$3,489,210 
    *Envista Stock Purchase AccountEnvista Stock Fund2,248 
    Total$3,491,458 
    PIMCO Total Return Fund Institutional ClassMutual Fund$16,676,942 
    PIMCO Inflation Response Multi-Asset Fund InstitutionalMutual Fund$3,191,510 
    Vanguard Equity Income FundMutual Fund289,205 
    Total$20,157,657 
    *Self-Directed Brokerage AccountSelf-Directed Brokerage Account$55,948,380 
    T. Rowe Price Blue Chip Growth Trust (Class T1)Common/ Collective Trust$75,009,041 
    BlackRock Life Path Index 2065 Non-Lendable Fund MCommon/ Collective Trust2,610,572 
    GW&K Small/Mid Cap Core Equity Collective Investment FundCommon/ Collective Trust28,538,314 
    Arrowstreet International Equity ACWI ex US CIT - Class ACommon/ Collective Trust15,554,060 
    The London Company Income Equity Collective Trust Class 1Common/ Collective Trust12,557,594 
    BlackRock Equity Index Non-Lendable Fund MCommon/ Collective Trust60,939,228 
    BlackRock MSCI ACWI ex-U.S. IMI Index Non-Lendable Fund RCommon/ Collective Trust8,678,241 
    BlackRock Russell 2500 Index Non-Lendable Fund MCommon/ Collective Trust6,638,971 
    BlackRock U.S Debt Index Non-Lendable Fund MCommon/ Collective Trust3,351,604 
    BlackRock LifePath Index Retirement Non-Lendable Fund MCommon/ Collective Trust28,006,201 
    BlackRock LifePath Index 2030 Non-Lendable Fund MCommon/ Collective Trust32,303,271 
    BlackRock LifePath Index 2035 Non-Lendable Fund MCommon/ Collective Trust42,140,403 
    BlackRock LifePath Index 2040 Non-Lendable Fund MCommon/ Collective Trust43,912,169 
    BlackRock LifePath Index 2045 Non-Lendable Fund MCommon/ Collective Trust49,020,654 
    BlackRock LifePath Index 2050 Non-Lendable Fund MCommon/ Collective Trust34,869,140 
    BlackRock LifePath Index 2055 Non-Lendable Fund MCommon/ Collective Trust22,859,410 
    BlackRock LifePath Index 2060 Non-Lendable Fund MCommon/ Collective Trust8,567,177 
    *Fidelity Managed Income Portfolio II Class 1Common/ Collective Trust19,757,106 
    Total$495,313,156 
    *Participant loansInterest rates range from 3.25% to 9.50% with maturity at various dates through July 2045$7,020,102 
    *Parties-in-interest.
    **Historical cost is not required for participant-directed investments
    11


    SIGNATURE

    Pursuant to the requirements of the Securities Exchange Act of 1934, the trustees (or other persons who administer the employee benefit plan) have duly caused this annual report to be signed on its behalf by the undersigned hereunto duly authorized.
     
      ENVISTA HOLDINGS CORPORATION SAVINGS PLAN
       
    June 11, 2025 By: /s/ Tony Bousquette
        Tony Bousquette
        Member of the 401(k) Committee for the Envista Holdings Corporation Savings Plan

    12


    EXHIBIT INDEX
     
    Exhibit
    Number
      Description
    23.1
      
    Consent of BDO USA, P.C., Independent Registered Public Accounting Firm

    13
    Get the next $NVST alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $NVST

    DatePrice TargetRatingAnalyst
    5/27/2025$23.00Neutral → Outperform
    Robert W. Baird
    12/4/2024$20.00Underperform
    Mizuho
    10/31/2024$16.00 → $23.00Underperform → Market Perform
    Leerink Partners
    10/8/2024$20.00Equal Weight
    Wells Fargo
    8/8/2024$23.00 → $16.00Overweight → Neutral
    JP Morgan
    4/26/2024$33.00 → $21.00Overweight → Equal-Weight
    Morgan Stanley
    2/26/2024$19.00Underperform
    Leerink Partners
    2/9/2024$30.00 → $23.00Buy → Hold
    Jefferies
    More analyst ratings

    $NVST
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Envista upgraded by Robert W. Baird with a new price target

      Robert W. Baird upgraded Envista from Neutral to Outperform and set a new price target of $23.00

      5/27/25 9:05:49 AM ET
      $NVST
      Medical/Dental Instruments
      Health Care
    • Mizuho initiated coverage on Envista with a new price target

      Mizuho initiated coverage of Envista with a rating of Underperform and set a new price target of $20.00

      12/4/24 7:46:09 AM ET
      $NVST
      Medical/Dental Instruments
      Health Care
    • Envista upgraded by Leerink Partners with a new price target

      Leerink Partners upgraded Envista from Underperform to Market Perform and set a new price target of $23.00 from $16.00 previously

      10/31/24 6:27:39 AM ET
      $NVST
      Medical/Dental Instruments
      Health Care

    $NVST
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G filed by Envista Holdings Corporation

      SC 13G - Envista Holdings Corp (0001757073) (Subject)

      11/8/24 12:09:03 PM ET
      $NVST
      Medical/Dental Instruments
      Health Care
    • SEC Form SC 13G/A filed by Envista Holdings Corporation (Amendment)

      SC 13G/A - Envista Holdings Corp (0001757073) (Subject)

      2/15/24 10:19:33 AM ET
      $NVST
      Medical/Dental Instruments
      Health Care
    • SEC Form SC 13G filed by Envista Holdings Corporation

      SC 13G - Envista Holdings Corp (0001757073) (Subject)

      2/14/24 4:08:38 PM ET
      $NVST
      Medical/Dental Instruments
      Health Care

    $NVST
    Financials

    Live finance-specific insights

    See more
    • Envista Reports First Quarter 2025 Results

      BREA, Calif., May 1, 2025 /PRNewswire/ -- Envista Holdings Corporation (NYSE:NVST) today announced results for the quarter ended March 28, 2025. "In the first quarter, Envista delivered results in line with our expectations building on the momentum established across the second half of 2024," said Paul Keel, CEO. "We continued to drive improvements across our three priority areas of growth, operations, and people. This was a solid start to the year, and we are maintaining our 2025 guidance." Q1 2025 financial highlights: Sales were $617 million, with core sales increasing 0.2%

      5/1/25 4:05:00 PM ET
      $NVST
      Medical/Dental Instruments
      Health Care
    • Envista Schedules First Quarter 2025 Earnings Call

      BREA, Calif., April 8, 2025 /PRNewswire/ -- Envista Holdings Corporation (NYSE:NVST) ("Envista") will report financial results for its first quarter 2025 on Thursday, May 1, 2025. Envista will discuss these results on a conference call on the same day beginning at 2:00 PM PT and lasting approximately one hour.  The call and the accompanying slide presentation will be webcast on the "Investors" section of Envista's website, www.envistaco.com. A replay of the webcast will be available shortly after the conclusion of the presentation and will remain available for one year. You ca

      4/8/25 4:15:00 PM ET
      $NVST
      Medical/Dental Instruments
      Health Care
    • Envista Reports Fourth Quarter 2024 Results

      BREA, Calif., Feb. 5, 2025 /PRNewswire/ -- Envista Holdings Corporation (NYSE:NVST) today announced results for the quarter ended December 31, 2024. "In Q4 2024, Envista delivered results that were in line with expectations, indicating that our focus on growth, operations, and people is having a positive impact," said Paul Keel, Envista's CEO.  "2024 was a transition year for our company.  After a challenging first half, we took actions over the last two quarters to position ourselves for improved performance moving forward.  While we still have much more to do, we're encourag

      2/5/25 4:05:00 PM ET
      $NVST
      Medical/Dental Instruments
      Health Care

    $NVST
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Chief Executive Officer Keel Paul A bought $506,100 worth of shares (30,000 units at $16.87), increasing direct ownership by 8% to 402,605 units (SEC Form 4)

      4 - Envista Holdings Corp (0001757073) (Issuer)

      8/14/24 4:40:20 PM ET
      $NVST
      Medical/Dental Instruments
      Health Care
    • Chief Financial Officer Hammes Eric D. bought $400,608 worth of shares (24,532 units at $16.33) (SEC Form 4)

      4 - Envista Holdings Corp (0001757073) (Issuer)

      8/13/24 6:01:10 PM ET
      $NVST
      Medical/Dental Instruments
      Health Care
    • Conley Eric bought $50,015 worth of shares (2,185 units at $22.89), increasing direct ownership by 5% to 47,376 units (SEC Form 4)

      4 - Envista Holdings Corp (0001757073) (Issuer)

      11/20/23 5:49:32 PM ET
      $NVST
      Medical/Dental Instruments
      Health Care

    $NVST
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Envista Announces Participation in Stifel 2025 Jaws & Paws Conference

      BREA, Calif., May 22, 2025 /PRNewswire/ -- Envista Holdings Corporation (NYSE:NVST) ("Envista") today announced that the company will participate in the Stifel 2025 Jaws & Paws Conference. The fireside chat will take place on Wednesday, May 28, 2025, from 1:50 – 2:20 pm ET. A live audio webcast of the event, along with an archived replay, will be available in the Investors section of the Envista website at https://investors.envistaco.com/.  ABOUT ENVISTA HOLDINGS CORPORATION Envista is a global family of more than 30 trusted dental brands, including Nobel Biocare, Ormco, DEXIS

      5/22/25 4:15:00 PM ET
      $NVST
      Medical/Dental Instruments
      Health Care
    • Hitachi Digital Services Announces Five-Year Strategic IT Partnership with Envista

      DALLAS, May 15, 2025 /PRNewswire/ -- Hitachi Digital Services, the digital consultancy and technology services subsidiary of Hitachi, Ltd. (TSE: 6501), today announced a five-year agreement with Envista Holdings Corporation (NYSE:NVST) ("Envista"), a global leader in dental care, to deliver end-to-end IT managed services across Envista's operations in more than 60 countries. Following a highly competitive tendering process, Envista selected Hitachi Digital Services as its strategic IT partner to support its digital transformation and operational efficiency goals. Under this ag

      5/15/25 11:23:00 AM ET
      $NVST
      Medical/Dental Instruments
      Health Care
    • Envista Reports First Quarter 2025 Results

      BREA, Calif., May 1, 2025 /PRNewswire/ -- Envista Holdings Corporation (NYSE:NVST) today announced results for the quarter ended March 28, 2025. "In the first quarter, Envista delivered results in line with our expectations building on the momentum established across the second half of 2024," said Paul Keel, CEO. "We continued to drive improvements across our three priority areas of growth, operations, and people. This was a solid start to the year, and we are maintaining our 2025 guidance." Q1 2025 financial highlights: Sales were $617 million, with core sales increasing 0.2%

      5/1/25 4:05:00 PM ET
      $NVST
      Medical/Dental Instruments
      Health Care

    $NVST
    Leadership Updates

    Live Leadership Updates

    See more
    • QuidelOrtho Announces Appointment of Two Independent Directors to its Board

      Veteran Healthcare CEOs John R. Chiminski and R. Scott Huennekens Bring Deep Industry Experience, Operational Expertise and Financial Acumen to the QuidelOrtho Board QuidelOrtho Corporation (NASDAQ:QDEL) (the "Company" or "QuidelOrtho"), a global provider of innovative in vitro diagnostic technologies designed for point-of-care settings, clinical labs and transfusion medicine, today announced the appointments of John R. Chiminski and R. Scott Huennekens to its board of directors (the "Board"), effective December 6, 2024. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241210769572/en/R. Scott Huennekens (Photo: Business Wire) T

      12/10/24 7:00:00 AM ET
      $CTLT
      $HYPR
      $NVST
      $QDEL
      Biotechnology: Pharmaceutical Preparations
      Health Care
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Medical/Dental Instruments
    • Compass Diversified Announces Stephen Keller as Chief Financial Officer

      WESTPORT, Conn., Aug. 26, 2024 (GLOBE NEWSWIRE) -- Compass Diversified (NYSE:CODI) ("CODI" or the "Company"), an owner of leading middle market businesses, announced today that Stephen Keller has been appointed as the Company's Chief Financial Officer (CFO), effective August 31, 2024. He will be replacing Ryan Faulkingham, who has served as the Company's CFO since July 2013 and is departing the Company effective August 30, 2024. Mr. Faulkingham will continue to serve in an advisory capacity in order to facilitate a seamless transition. In his new role, Mr. Keller will lead CODI's finance organization, including accounting, planning, treasury, tax, reporting, and investor relations. He b

      8/26/24 6:00:00 AM ET
      $AVY
      $CODI
      $NVST
      Containers/Packaging
      Consumer Discretionary
      Home Furnishings
      Medical/Dental Instruments
    • Envista Holdings Corporation Announces Key Leadership Appointments

      BREA, Calif., July 15, 2024 /PRNewswire/ -- Envista Holdings Corporation (NYSE:NVST) today announced the following key leadership appointments: Eric Hammes joins Envista as Chief Financial OfficerStefan Nilsson joins Envista as President, Nobel BiocareVeronica Acurio joins Envista as President, Ormco"It is a pleasure to welcome this trio of successful leaders to Envista," said Paul Keel, Chief Executive Officer. "Each brings experience in dental along with a proven track record of continuous improvement, leading with purpose, and creating value for all stakeholders. Today's an

      7/15/24 4:10:00 PM ET
      $NVST
      Medical/Dental Instruments
      Health Care

    $NVST
    SEC Filings

    See more
    • Envista Holdings Corporation filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits

      8-K - Envista Holdings Corp (0001757073) (Filer)

      6/12/25 4:49:31 PM ET
      $NVST
      Medical/Dental Instruments
      Health Care
    • SEC Form 11-K filed by Envista Holdings Corporation

      11-K - Envista Holdings Corp (0001757073) (Filer)

      6/11/25 4:13:17 PM ET
      $NVST
      Medical/Dental Instruments
      Health Care
    • SEC Form SD filed by Envista Holdings Corporation

      SD - Envista Holdings Corp (0001757073) (Filer)

      5/30/25 4:39:21 PM ET
      $NVST
      Medical/Dental Instruments
      Health Care

    $NVST
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Gallahue Kieran was granted 10,450 shares, increasing direct ownership by 31% to 44,680 units (SEC Form 4)

      4 - Envista Holdings Corp (0001757073) (Issuer)

      6/12/25 4:55:53 PM ET
      $NVST
      Medical/Dental Instruments
      Health Care
    • Director Raskas Daniel was granted 10,450 shares, increasing direct ownership by 31% to 44,680 units (SEC Form 4)

      4 - Envista Holdings Corp (0001757073) (Issuer)

      6/12/25 4:55:43 PM ET
      $NVST
      Medical/Dental Instruments
      Health Care
    • Director Jain Vivek was granted 10,450 shares, increasing direct ownership by 32% to 43,615 units (SEC Form 4)

      4 - Envista Holdings Corp (0001757073) (Issuer)

      6/12/25 4:55:34 PM ET
      $NVST
      Medical/Dental Instruments
      Health Care